New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researc...
Alzheimer’s disease and Parkinson’s disease, along with stroke, are among the to...
Despite a failed bid to expand Imfinzi’s treatment scope in NSCLC, the drug has ...
GSK’s Trelegy Ellipta has been approved as a maintenance therapy for both asthma...
Last month, Amylyx announced that the Phase III confirmatory trial of ALS drug R...
Recent campaigns have targeted children and young adults in low vaccine uptake a...
Acumen has entered a partnership with Lonza to further the development of sabirn...
MiNA Therapeutics has entered into an agreement with Nippon Shinyaku to develop ...
Caris Life Sciences has entered a collaboration with Merck KGaA for the developm...
The UK MHRA has approved Advanz Pharma’s combined antibiotic, cefepime/enmetazob...
The director of BARDA’s medical countermeasures programs, Robert Johnson, talks ...
Inter-atrial shunts—investigational devices that create a small pathway for bloo...
A new study by researchers at the Department of Environmental Science, Stockholm...
The rapid progress of quantum simulators is now enabling them to study problems ...
Woods Hole, Mass– The human gut is full of microbes. Some microbes can make peop...
Boston – Numerous studies conducted by researchers at Dana-Farber Cancer Institu...
